Sunday, February 15, 2026 2/15/2026

Systems Approaches for Opening Therapeutic Windows

Award Number: DP2AT011327
ORGANIZATION: CENTER FOR DRUG EVALUATION AND RESEARCH, NIH
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 08/15/2020
PERIOD OF PERFORMANCE END DATE: 06/30/2025

Group Awards By:

View Award Description

Systems Approaches for Opening Therapeutic Windows - Project Summary/Abstract The overwhelming majority of drugs in development fail. This is a major problem; solutions to this problem offer potential to benefit humanity by increasing the number of drugs available to treat and help ailing individuals. Drug companies have a set of tools that enable them to manipulate the biochemical properties of drugs, but the ultimate success or failure of a drug reflects how the drug affects physiological systems. This project is based on the idea better drug development strategies that result in wide and favorable therapeutic windows can be developed through the consideration of systems behaviors. The first major component of this project investigates the hypothesis that failed drugs can be converted into clinically useful drugs through co- treatment with another drug that targets the same biological network to “open the therapeutic window”. New screening approaches will be developed that are optimized to detect therapeutic windows. These screens will then be applied to high-priority drug targets for which good drugs with favorable therapeutic windows have largely evaded development. Candidate window openers will be experimentally validated. The second major component of this project investigates the hypothesis that the mechanisms by which pathogenic variants promote disease within biological systems can be categorized into recurrent classes of “disease network motifs”. Additionally, it is hypothesized that analysis of disease network motifs can identify targetable vulnerabilities that will apply to the different maladies that are promoted through the corresponding disease network motif. Mathematical and bioinformatic approaches will be used to classify disease network motifs and to identify their nodes that are likely to have therapeutic windows. Experiments will test the vulnerabilities identified through this analysis. One set of experiments will focus on existing drugs that can serve as archetype examples for the disease network motif vulnerabilities. The other set of experiments will utilize the disease network motif approach to identify new subsets of patients who may be treatable through currently FDA approved agents. Overall, the proposed research aims to provide a systems perspective to an area of drug development that needs new strategies to identify the drug targets most likely to result in clinically useful agent. If successful, this project could make the drug development process more efficient and more productive, in turn, providing more benefit to more patients more rapidly.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = -$196 )
2025	2020	YALE UNIV	150 MUNSON ST	NEW HAVEN	CT	06511	SOUTH CENTRAL CT	USA	Trans-NIH Research Support	000	2	9/12/2025	CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION	-$196
														Subtotal = -$196

Issue Date FY: 2023 ( Subtotal = $0 )
2023	2020	YALE UNIVERSITY	105 WALL ST	NEW HAVEN	CT	06511	SOUTH CENTRAL CT	USA	Trans-NIH Research Support	001	2	12/6/2022	CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION	$196
2023	2020	SALK INSTITUTE FOR BIOLOGICAL STUDIES, SAN DIEGO, CALIFORNIA, THE	10010 N TORREY PINES RD	LA JOLLA	CA	92037	SAN DIEGO	USA	Trans-NIH Research Support	000	1	12/6/2022	NEW	-$196
														Subtotal = $0

Issue Date FY: 2022 ( Subtotal = -$316,724 )
2022	2020	YALE UNIVERSITY	105 WALL ST	NEW HAVEN	CT	06511	SOUTH CENTRAL CT	USA	Trans-NIH Research Support	001	2	9/12/2022	CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION	$2,130,573
2022	2020	SALK INSTITUTE FOR BIOLOGICAL STUDIES, SAN DIEGO, CALIFORNIA, THE	10010 N TORREY PINES RD	LA JOLLA	CA	92037	SAN DIEGO	USA	Trans-NIH Research Support	000	1	9/12/2022	NEW	-$2,447,297
														Subtotal = -$316,724

Issue Date FY: 2020 ( Subtotal = $2,886,000 )
2020	2020	SALK INSTITUTE FOR BIOLOGICAL STUDIES, SAN DIEGO, CALIFORNIA, THE	10010 N TORREY PINES RD	LA JOLLA	CA	92037	SAN DIEGO	USA	Trans-NIH Research Support	000	1	8/4/2020	NEW	$2,886,000
														Subtotal = $2,886,000

Grand Total All Awards = $2,569,080

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Systems Approaches for Opening Therapeutic Windows

Award Number: DP2AT011327

ORGANIZATION: CENTER FOR DRUG EVALUATION AND RESEARCH, NIH

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 08/15/2020

PERIOD OF PERFORMANCE END DATE: 06/30/2025

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer